Hoth Therapeutics, Inc.

Hoth Therapeutics Inc. is a biopharmaceutical company engaged in the development of new therapies for dermatological and other conditions. The company's primary focus is on creating effective treatments for skin diseases and disorders, utilizing advanced research to target unmet medical needs. Hoth Therapeutics collaborates extensively with various medical research institutions, aiming to leverage innovative biotechnology and drug development techniques to meet healthcare demands. The company's pipeline includes topical applications and drugs addressing conditions such as eczema, psoriasis, and skin infections, potentially impacting both the dermatology and broader pharmaceutical sectors. Headquartered in New York, Hoth Therapeutics also explores partnerships to enhance the development and commercialization of its products, positioning itself as a key player in the niche medical fields it targets. Through its innovative approaches and commitment to healthcare solutions, Hoth Therapeutics Inc. contributes significantly to advancements in the biopharma market.